User menu

A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel

Bibliographic reference Maison-Blanche, Pierre ; Vermorken, Jan B ; Goksel, Tuncay ; Machiels, Jean-Pascal ; Agarwala, Sanjiv ; et. al. A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel. In: Journal of Cardiovascular Pharmacology, Vol. 61, no.6, p. 495-504 (2013)
Permanent URL http://hdl.handle.net/2078.1/140348